Market research
GKO.F GlycoMimetics, Inc
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 9M
- P/E ratio
- Not available
- Analyst target
- 10.67
- Dividend yield
- Not available
- Beta
- 1.6
Community
Investor discussion
1 comment
Sign in to join the GKO.F discussion.
5 years, 5 months ago
GlycoMimetics, Inc is currently in a long term downtrend where the price is trading 34.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.4.
GlycoMimetics, Inc's total revenue rose by inf% to $163K since the same quarter in the previous year.
Its net income has dropped by 5.7% to $-16M since the same quarter in the previous year.
Finally, its free cash flow grew by 24.1% to $-10M since the same quarter in the previous year.
Based on the above factors, GlycoMimetics, Inc gets an overall score of 3/5.